Pacira BioSciences (NASDAQ:PCRX) just reported results for the second quarter of 2024.
- Pacira BioSciences reported earnings per share of 89 cents. This was above the analyst estimate for EPS of 70 cents.
- The company reported revenue of $178.02 million.
- This was 3.21% better than the analyst estimate for revenue of $172.48 million.